Summary
Thermo Fisher Scientific is increasing its investment in India, driven by the anticipated growth in biosimilars and innovative medicines, with Indian pharmaceutical companies focusing on advanced biologics. The company has also established a bioprocess center in Hyderabad to train scientific talent.